Uncategorized

There Is Nothing Wrong With Health Benefits


Elizabeth Warren says she has “never met anyone who loves their health insurance company” and enjoys insurance companies by increasing “their profits by saying ‘no’ to earn.” Well-known health writer and journalist Elisabeth Rosenthal refers to insurance companies as “competent scams,” who are embroiled in a scandal involving drug companies and hospitals, who have selfishly robbed of their prices.

DOWNLOAD HERE

Undoubtedly, the US health care system has become increasingly greedy, as drug companies, equipment manufacturers, hospital associations, medical teams, and insurance brokers try to recoup more than the $ 3 trillion we spend on medical care each year. Too bad, such selfishness leads people like “pharmacy brother” Martin Shkreli to increase their prices by 10, 100, or more, placing less expensive medical care in an area where people who need it do not have access. But venting our anger on greedy drug lords or cruel hospital officials is dangerous, enticing us to think that the American healthcare problem is a bad one or a bad industry — which makes us think, if we can embarrass CEOs in delivering or taxing. in the health insurance industry, our problems will be solved.

The problem with American health care is not the presence of greed. These are the rules that greedy people must follow to make money. The key to transforming American health care is not demonizing, but changing the rules of health care reimbursement.

Consider the shameful practice among many cancer experts. Some of them offer unnecessary chemotherapy to get their patients to their goals. This behavior is promoted by our reimbursement system known as “purchasing and billing,” in which oncology procedures purchase medicines, give them to their patients, and charge medical insurance companies after marking a 6% price increase. As a result of this collection, when the popular lung cancer drug became available in general, many oncologists switched to a rival drug that, although no longer effective in treating human cancer, could only be found in its more expensive, nominal form. 6% marking on a cheap generic drug would threaten the oncologist’s financial limit.

It is easy to include demonic oncologists who have chosen to switch to more expensive chemical treatments, or oncology administrators. Providing expensive medical treatment hurt many patients, who were forced to pay a small portion of the price of the drug in a pocket. It has also hurt the country, contributing to the unnecessary cost of medical care. On the other hand, many oncology procedures rely on “buy and pay” packages to maintain the size and capacity of their office staff.

Leave a Reply

Your email address will not be published. Required fields are marked *